Characteristics | Total (nā=ā142) | Control (nā=ā71) | DC-CIK (nā=ā71) | p value |
---|---|---|---|---|
Sex, male/female | 79/63 | 40/31 | 39/32 | 0.44 |
Age (years), meanāĀ±āSD | 55.4āĀ±ā14.4 | 55.6āĀ±ā14.3 | 55.3āĀ±ā14.6 | 0.90 |
KPS, meanāĀ±āSD | 70.4āĀ±ā6.3 | 70.1āĀ±ā5.7 | 70.6āĀ±ā6.8 | 0.79 |
Adenocarcinoma | ||||
āWell differentiated | 3 | 2 | 1 | 0.75 |
āModerately differentiated | 104 | 54 | 50 | Ā |
āPoorly differentiated | 22 | 9 | 13 | Ā |
āUnknown | 13 | 6 | 7 | Ā |
TNM stage (III/IV) | 98/54 | 41/30 | 47/24 | 0.27 |
FOLFIRI chemotherapy cycles | ||||
āā¤ā3 | 32 | 19 | 15 | 0.59 |
ā4ā6 | 33 | 18 | 16 | Ā |
ā>ā6 | 44 | 21 | 24 | Ā |
Radiotherapy (yes/no) | 49/93 | 22/49 | 27/44 | 0.31 |